Health Canada
- Status: approved
Clindamycin palmitate hydrochloride dispersible tablet (Clindamycin palmitate hydrochloride dispersible tablet) regulatory status in Canada.
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. Health Canada has authorised it.
Guangzhou Yipinhong Pharmaceutical CO.,LTD is the originator. The local marketing authorisation holder may differ — check the official source linked above.